Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|December 31, 2013
GI-4000 in KRAS mutant cancersSafi Shahda, Bert O'NeilWorld Journal of Gastrointestinal Oncology|December 23, 2015
Targeted therapy for advanced gastric cancer: A review of current status and future prospectsOzkan Kanat, Bert O'Neil, Safi ShahdaBMC Cancer|May 19, 2019
Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective studyOlumide B Gbolahan, Yan Tong, Amikar Sehdev, et al.American Journal of Clinical Oncology|October 3, 2017
Clinical Characteristics of Patients Experiencing Pathologic Complete Response Following Neoadjuvant Therapy for Borderline Resectable/Locally Advanced Pancreatic AdenocarcinomaNeda Hashemi-Sadraei, Olumide B Gbolahan, Hai Salfity, et al.Expert Review of Clinical Pharmacology|May 10, 2013
Regorafenib: from bench to bedside in colorectal cancerSafi Shahda, Muhammad Wasif SaifGastrointestinal Endoscopy|September 18, 2018
Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancerJohn M DeWitt, Kumar Sandrasegaran, Bert O'Neil, et al.The Journal of Invasive Cardiology|October 2, 2007
Stents in the successful management of protein-losing enteropathy after fontanSafi Shahda, Michael Zahra, Andrew Fiore, et al.Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
A Phase I study targeting the APE1/Ref-1 redox signaling protein with APX3330: First clinical agent targeting APE1/Ref-1 in CancerMark R Kelley, Jun Wan, Sheng Liu, et al.Translational Gastroenterology and Hepatology|April 13, 2019
Update on systemic therapy for colorectal cancer: biologics take sidesOlumide Gbolahan, Bert O'NeilAnticancer Research|October 7, 2017
Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic CancerNeelakanta Dadi, Melissa Stanley, Safi Shahda, et al.Pageof 7